LabNorms Population Percentiles

Fasting Insulin

Males, Age 30-39

The median fasting insulin for US males aged 30-39 is 9.1 µU/mL (55 pmol/L), with 90% of the population falling between 3.1 µU/mL and 39.7 µU/mL.

NHANES 2017-March 2020 Pre-Pandemic 2017-2020 · Sample size: 244 participants · Unit: µU/mL

Percentile Distribution

Unit:
Percentile P5P10P25P50P75P90P95
Value (µU/mL) 3.1 3.9 6.4 9.1 16.5 28.1 39.7
95% CI 2 to 3.8 3 to 4.9 5 to 7.3 7.8 to 11.7 13.6 to 19.7 20.6 to 39.3 31.7 to 69.8
Percentile Value (µU/mL) 95% CI
P5 3.1 2 to 3.8
P10 3.9 3 to 4.9
P25 6.4 5 to 7.3
P50 9.1 7.8 to 11.7
P75 16.5 13.6 to 19.7
P90 28.1 20.6 to 39.3
P95 39.7 31.7 to 69.8

The 95% confidence interval (CI) is the range of values for the population percentile that are consistent with this sample, given how NHANES selected participants. It describes uncertainty in the percentile, not in any one person's result.

Data and Methodology

Dataset
NHANES 2017-March 2020 Pre-Pandemic ( NHANES 2017-2020 2020 , Survey-weighted percentiles from fasting subsample)
Survey years
2017-2020
Measurement
Measured by two-site immunoenzymometric assay on Tosoh AIA-900. How it was measured
Sample size
244 participants
Reference population
US civilian non-institutionalized males aged 30-39 from NHANES 2017-March 2020. Includes the full population (not restricted to healthy individuals) to reflect the population distribution.
Exclusion criteria
  • Missing fasting insulin measurement (LBXIN)
  • Missing or zero fasting sample weight (WTSAF)
  • Age outside 30-39 range
Notes
Percentiles computed using the combined pre-pandemic fasting-subsample weight (WTSAFPRP). Fasting insulin measured as LBXIN in µU/mL from the fasting subsample. Corrected October 2026: the previous version of these figures counted 257 participants in this group, including 13 who did not meet the fasting requirement of 8 to under 24 hours.

Other Demographic Groups